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Abstract
In order to assess the molecular epidemiology of HIV-1 in two
neighboring cities located near the epicenter of the HIV-1 epidemics
in Brazil (Santos and Sªo Paulo), we investigated 83 HIV-1 strains
obtained from samples collected in 1995 from intravenous drug users.
The V3 through V5 region of the envelope of gp 120 was analyzed by
heteroduplex mobility analysis. Of the 95 samples, 12 (12.6%) were
PCR negative (6 samples from each group); low DNA concentration
was the reason for non-amplification in half of these cases. Of the 42
typed cases from Sªo Paulo, 34 (81%, 95% confidence limits 74.9 to
87.0%) were B and 8 (19%, 95% confidence limits 12.9 to 25.0%)
were F, whereas of the 41 typed cases from Santos, 39 (95%, 95%
confidence limits 91.6 to 98.4%) were B and 2 (5%, 95% confidence
limits 1.6 to 8.4%) were C. We therefore confirm the relationship
between clade F and intravenous drug use in Sªo Paulo, and the
presence of clade C in Santos. The fact that different genetic subtypes
of HIV-1 are co-circulating indicates a need for continuous surveil-
lance for these subtypes as well as for recombinant viruses in Brazil.
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A total of 128,821 clinical cases of AIDS
had been reported in Brazil up to February
1998, and it is estimated that as many as
580,000 individuals are currently infected
with HIV (1). Almost 72% of the reported
cases were from the southeast region of the
country, with Sªo Paulo city accounting for
25% of them (1). The distribution of AIDS
incidence in 1996 and 1997 among various
groups was 24% among homo-bisexual
males, 20.2% among intravenous drug users
(IDU), 32.5% among heterosexual individu-
als with known sexual exposure, and 23.3%
among individuals with unknown transmis-
sion route. As is the case for many develop-
ing countries, more than one co-circulating
clade of HIV-1 are present in Brazil. Overall,
the predominant strain is clade B, accounting
for 90% of the characterized strains, clade F
accounts for 5-8%, and clades C and D repre-
sent less than 2% of the total (2-6).
In a previous study we suggested that
subtype F was related to IDU in Brazil (5). In
the latter study, however, only a few cases of
IDU and their sexual partners from an AIDS
clinic in Sªo Paulo city were available. In the
present study, we not only expanded the
survey of the IDU population from Sªo Paulo
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city, but also accessed the IDU population of
Santos, a city located 60 km from Sªo Paulo.
Santos is a port city with a very high preva-
lence of HIV infection, where as many as
61% of the infected individuals are IDUs.
We prospectively analyzed a total of 95 con-
secutive samples collected from HIV-1-in-
fected IDUs: 48 patients attending an outpa-
tient AIDS clinic at the Federal Medical
University of Sªo Paulo and 47 from the
outpatient clinics of the Reference Center
for AIDS in Santos. In both centers, mean
patient age was 33 years, and 18% of them
were females. Samples were collected in
1995. Peripheral blood mononuclear cells
were obtained after saponin lysis of whole
blood, digested with proteinase-K, and sub-
jected to alcohol precipitation for DNA iso-
lation. Amplification of a portion of the env
gene was carried out by nested PCR, and the
resulting fragment was used for HIV-1
subtyping by heteroduplex mobility analysis
(7).
Of the 95 samples, 12 (12.6%) were PCR
negative (6 samples from each group), with
low DNA concentration being the reason for
non-amplification in half of these cases. Of
the 42 typed cases from Sªo Paulo, 34 (81%)
were B and 8 (19%) were F, whereas of the
41 typed cases from Santos, 39 (95%) were
B and 2 (5%) were C (Table 1). One of the
individuals from Santos, subtyped as C, was
HIV positive since 1986, suggesting that this
virus has been circulating in Brazil for a long
time. Therefore, our results confirm a high
prevalence of clade F in the IDU population
of Sªo Paulo, but not of its neighbor city of
Santos, although the sampling size of this
study is still limited.
According to Leitner (8), phylogenetic
analysis of HIV-1 subtypes suggests that the
epidemic evolved in two phases; an early
phase, in which the virus spread more slowly
between host groups in Africa, generating a
network of variants, and a more recent and
still ongoing phase, in which a particular
variant of the virus reached and spread rap-
idly in naive populations. This is the so-
called founder effect which is responsible
for the vast preponderance of subtype B
circulating in Europe and in the Americas.
The next phase of the epidemic will likely be
dynamic competition between the prevalent
co-circulating strains present in some re-
gions of the world. Some strains may pre-
vail, either due to different inherent biologi-
cal properties of the viruses or to epidemio-
logical host reasons. It is now recognized
that clade E overwhelmed clade B in the IDU
population in Thailand (9), and that clade C
is expanding out of proportion in Africa
(10).
The distribution of HIV subtypes in Bra-
zil seems to be quite complex since their
prevalence may differ significantly even be-
tween neighboring cities where the epidemic
started at about the same time. It will be
important to monitor the HIV subtype pro-
files in Brazil during the next phase of the
epidemic, when competition among clades
is expected to occur, bearing in mind that the
distribution of subtypes has local determi-
nants, and that data from one site cannot be
generalized to the entire country or even to a
single geographic region.
Table 1 - Distribution of HIV-1 subtypes in São
Paulo and Santos (Brazil).
Subtype was determined by heteroduplex mobil-
ity analysis. The prevalence of subtype F was
higher in São Paulo than in Santos (P = 0.002, chi-
square test).
City Subtype profile, N (%) Total
B C F
São Paulo 34 (81) 0 8 (19) 42
Santos 39 (95) 2 (5) 0 41
Total 73 (88) 2 (2.4) 8 (9.6) 83
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